CBUS Cibus Inc
- 10.840
- -0.260-2.34%
Cibus Inc News
Cibus to Participate in Upcoming June Investor Events
SAN DIEGO, June 05, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today anno
Sector Update: Tech Stocks Slipping Tuesday Afternoon
Tech stocks were declining Tuesday afternoon, with the Technology Select Sector SPDR Fund (XLK) decreasing 0.2% and the SPDR S&P Semiconductor ETF (XSD) down 1.9%. The Philadelphia Semiconductor index
Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Core & Main Inc (NYSE:CNM) fell sharply during Tuesday's session after the company reported mixed first-quarter financial results.Core & Main posted quarterly earnings of 49 cents per share,
Cibus Tumbles After Short-Seller Report Alleges Few Commercial Products, Diminishing Resources
Cibus (CBUS) was retreating in Tuesday trading, recently sinking more than 9%, following a short-seller report by Bonitas Research contending the agricultural technology firm has had little success de
Medifast, Beauty Health Among Consumer Staples Additions in Russell Microcap; PLBY Group, Rocky Mountain Chocolate Removed
Russell 3000: Veru, Life MD Among Consumer Staple Additions; Benson Hill, PetMed Express Among Deletions
Cibus' White Mold (Sclerotinia) Resistance Trait Program Confirms Important Milestone for Next Generation Gene Edits in Canola
Cibus has successfully made the edits in Canola associated with the Company's 3rd mode of action for its White Mold (Sclerotinia) trait These next generation edits are now confirmed in plants and will
Cibus to Participate in the BMO Global Farm to Market Conference
SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic
Earnings Call Summary | Cibus Inc(CBUS.US) Q1 2024 Earnings Conference
The following is a summary of the Cibus, Inc. (CBUS) Q1 2024 Earnings Call Transcript:Financial Performance:Cibus reported a net loss of $27 million for Q1 2024, increasing significantly from a net lo
HC Wainwright & Co. : The Cibus (CBUS.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $25.00.
HC Wainwright & Co. : The Cibus (CBUS.US) rating was reaffirmed and adjusted from buy to buy, with a target price of $25.00.
HC Wainwright & Co. Reiterates Buy on Cibus, Maintains $25 Price Target
HC Wainwright & Co. analyst Amit Dayal reiterates Cibus (NASDAQ:CBUS) with a Buy and maintains $25 price target.
Cibus Q1 2024 GAAP EPS $(1.12) Up From $(5.46) YoY, Sales $545.000K Up From $42.000K YoY
Cibus (NASDAQ:CBUS) reported quarterly losses of $(1.12) per share. This is a 79.49 percent increase over losses of $(5.46) per share from the same period last year. The company reported $545.000 tho
Cibus (CBUS.US): The 2024 Q1 financial report achieved revenue of $545,000, the previous value was US$42,000, and the expected value was US$390,000; earnings per share were -1.12 US dollars, the previous value was -5.46 US dollars, and the expected value
Cibus (CBUS.US): The 2024 Q1 financial report achieved revenue of $545,000, the previous value was US$42,000, and the expected value was US$390,000; earnings per share were -1.12 US dollars, the previous value was -5.46 US dollars, and the expected value was -1.01 US dollars.
Cibus Inc | 10-Q: Quarterly report
Earnings Flash (CBUS) CIBUS US LLC Reports Q1 Revenue $545,000, Vs. Street Est of $395,000
04:10 PM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (CBUS) CIBUS US LLC Reports Q1 Revenue $545,000, vs. Street Est of $395,000
Cibus to Report First Quarter 2024 Financial Results on May 9, 2024 and Host Conference Call
SAN DIEGO, April 25, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or spe
Cibus Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
Market Fluctuations and Cibus Inc.: Navigating the Uncertain Terrain of Agricultural Commodity Prices
Cibus Is Maintained at Buy by HC Wainwright & Co.
Cibus Is Maintained at Buy by HC Wainwright & Co.
HC Wainwright & Co. Maintains Buy on Cibus, Maintains $25 Price Target
HC Wainwright & Co. analyst Amit Dayal maintains Cibus with a Buy and maintains $25 price target.
Analysis
Price Target
No Data
